- 関
- antilipemic drug、hypolipidemic、hypolipidemic agent、hypolipidemic drug、hypolipidemics、lipid-lowering agent、lipid-lowering drug
WordNet
- a substance that exerts some force or effect
- a businessman who buys or sells for another in exchange for a commission (同)factor, broker
- any agent or representative of a federal agency or bureau (同)federal agent
- a representative who acts on behalf of other persons or organizations
- an active and efficient cause; capable of producing a certain effect; "their research uncovered new disease agents"
- how long something has existed; "it was replaced because of its age"
- a time of life (usually defined in years) at which some particular qualification or power arises; "she was now of school age"; "tall for his eld" (同)eld
- begin to seem older; get older; "The death of his wife caused him to age fast"
- make older; "The death of his child aged him tremendously"
PrepTutorEJDIC
- 『代理人』;周旋人 / 働き(作用)を起こすもの;作用物,薬剤 / (政府機関,特にFBI,CIAなどの)部員,機関員
- 〈U〉(一般に)『年齢』,寿命;〈C〉(個々の)『年齢』,年 / 〈U〉成年(おとなとしての資格・権利を得る年齢;通例18または21歳) / 〈U〉『老齢』;《集合的に》老人たち / 〈U〉(人生の)『一時期』;〈C〉世代(generation) / 〈U〉〈C〉《しばしばA-》(歴史上の)『時代』 / 〈C〉《話》長い間 / 年をとる,ふける;〈物が〉古くなる / 〈年〉'を'とらせる;〈物〉'を'古びさせる
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Statins and Cognitive Side Effects: What Cardiologists Need to Know.
- Rojas-Fernandez C1, Hudani Z2, Bittner V3.
- Endocrinology and metabolism clinics of North America.Endocrinol Metab Clin North Am.2016 Mar;45(1):101-16. doi: 10.1016/j.ecl.2015.09.007.
- Statins are widely used in secondary and primary prevention of atherosclerotic cardiovascular disease. They reduce cardiovascular events and mortality, and have an excellent safety record. Recent case reports suggest a possible association between statins and adverse effects on cognition. This artic
- PMID 26893000
- Statins and cognitive side effects: what cardiologists need to know.
- Rojas-Fernandez C1, Hudani Z2, Bittner V3.
- Cardiology clinics.Cardiol Clin.2015 May;33(2):245-56. doi: 10.1016/j.ccl.2015.02.008.
- Statins are widely used in secondary and primary prevention of atherosclerotic cardiovascular disease. They reduce cardiovascular events and mortality, and have an excellent safety record. Recent case reports suggest a possible association between statins and adverse effects on cognition. This artic
- PMID 25939297
- Niacin as a drug repositioning candidate for hyperphosphatemia management in dialysis patients.
- Shin S1, Lee S1.
- Therapeutics and clinical risk management.Ther Clin Risk Manag.2014 Oct 14;10:875-83. doi: 10.2147/TCRM.S71559. eCollection 2014.
- Nearly all patients with end-stage renal disease develop hyperphosphatemia. These patients typically require oral phosphate binders for life-long phosphorus management, in addition to dietary restrictions and maintenance dialysis. Recently, niacin, a traditional antilipemic agent, drew attention as
- PMID 25342908
Japanese Journal
- Angioscopic Evaluation of Stabilizing Effects of an Antilipemic Agent, Bezafibrate, on Coronary Plaques in Patients with Coronary Artery Disease.:<b>A Multicenter Prospective Study</b>
- Ohsawa Hidefumi,Uchida Yasumi,Fujimori Yoshiharu,Hirose Junichi,Noike Hirofumi,Tokuhiro Keiichi,Kawamura Kohei,Kanai Masahito,Sakuragawa Hiroshi,Hitsumoto Takashi,Aoyagi Kaneyuki,Sakurai Takeshi,Sato Shin,Yoshinaga Kunio,Kaku Michihisa,Ozegawa Masaaki,Morio Hiroshi,Yamada Katsumi,Terasawa Kimiko,Uchida Yuuko,Ohshima Tomomitsu
- Japanese Heart Journal 43(4), 319-331, 2002
- … To evaluate the stabilizing effects of an antilipemic agent, bezafibrate, on coronary plaques, we carried out a prospective angioscopic and angiographic open trial. …
- NAID 130000070885
- Preparation of Aminated Fucoidan and Its Evaluation as an Antithrombotic and Antilipemic Agent
- 添田 秦司,大曲 祐介,占野 廣司,永松 淳雄
- Ｂｉｏｌｏｇｉｃａｌ ＆ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｂｕｌｌｅｔｉｎ 17(6), 784-788, 1994-06-15
- … The present results that the anticoagulant and antilipemic potency of fucoidan can be improved by charge modification may provide useful clues for the development of an ideal anticoagulant and antilipemic drug. …
- NAID 110003640643
Related Links
- antihyperlipidemic [an″te-, an″ti-hi″per-lip″ĭde´mik] 1. promoting a reduction of lipid levels in the blood. 2. an agent that promotes a reduction of lipid levels in the blood. antilipemic /an·ti·li·pe·mic/ (-lĭ-pe´mik) antihyperlipidemic.
- In medicine, antilipemic agents are medications for the treatment of hypercholesterolemia and hypertriglyceridemia. [1] Contents 1 Classification 1.1 Hydroxymethylglutaryl-coenzyme A reductase inhibitors (statins) 1.2 Bile acid ...
★リンクテーブル★
[★]
- 関
- antilipemic agent、antilipemic drug、hypolipidemic、hypolipidemic agent、hypolipidemic drug、hypolipidemics、lipid-lowering agent
[★]
- 関
- antilipemic agent、antilipemic drug、hypolipidemic、hypolipidemic agent、hypolipidemic drug、hypolipidemics、lipid-lowering drug
[★]
- 関
- antilipemic agent、antilipemic drug、hypolipidemic agent、hypolipidemic drug、hypolipidemics、lipid-lowering、lipid-lowering agent、lipid-lowering drug
[★]
- 関
- antilipemic agent、hypolipidemic、hypolipidemic agent、hypolipidemic drug、hypolipidemics、lipid-lowering agent、lipid-lowering drug
[★]
- 英
- lipid-lowering agent、antilipemic drug、antilipemic agent
- 関
- 抗高脂血症薬、抗脂血剤、抗高脂血症剤、抗高脂血薬、高脂血症薬、高脂血症治療薬
[★]
- 代行者、代理人。代理業者
- 政府職員、官吏
- ある後位をする人、ある作用をするもの。動員、動力因、作用因。(文法)動作主。科学的変化を起こさせるもの、薬品、～剤。病原体
- 関
- agonist、agonistic、attorney、delegate、drug、etiologic agent、fomes、fomites、mediator、pathogen、pathogenic、pharmaceutical preparation、vector、vehicle
[★]
- 関
- aged、ageing、aging、year old